drug interaction(s) of statins with fibrates

Drug interactions

• clinical benefit of statin-fibrate combinations is unclear
• no evidence of additional cardiovascular risk reduction over statin alone
• risk of rhabdomyolysis or severe myalgia is significantly increased with combination therapy
• risk appears to be dose-dependent

More general terms

• drug interaction